We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 402

California Passes Sweeping Prescription Drug Price Transparency Law and Co-Pay Coupon Ban
  • Sidley Austin LLP
  • USA
  • October 18 2017

Earlier this month, California passed two bills with significant implications for pharmaceutical manufacturers: one imposing prescription drug price

OIG Expands Anti-Kickback Statute and Civil Monetary Penalties Protections (Part 2)
  • Squire Patton Boggs
  • USA
  • March 29 2017

As we discussed in a previous post, the Department of Health and Human Services Office of Inspector General (OIG) published a final rule (Final Rule

TCCWNA Updates
  • Hunton & Williams LLP
  • USA
  • February 27 2017

TCCWNA case law has continued to develop with no end in sight. Recently, courts have grappled with definitional questions that could impact the scope

Analysis of HHS OIG Final Rule to Amend the Anti-Kickback Safe Harbors and CMP Rules on Beneficiary Inducements
  • Reed Smith LLP
  • USA
  • February 1 2017

On December 7, 2016, the Office of Inspector General (OIG) of the Department

New Final Regulations Provide Overdue Guidance on Permissible Arrangements Between Providers, Financial Relief for Patients
  • Arent Fox LLP
  • USA
  • December 7 2016

Over two years after proposing rules for comment, the Office of Inspector General for the Department of Health and Human Services (OIG) just

GAO, OIG Issue Reports on Medicare Part B Drug Payment Issues
  • Reed Smith LLP
  • USA
  • September 13 2016

The HHS Office of Inspector General (OIG) and the Government Accountability Office (GAO) recently issued several reports on various Medicare Part B

CFPB Enters Consent Order with Wells Fargo Over Payment Allocation Procedures
  • Smith Debnam Narron Drake Saintsing & Myers LLP
  • USA
  • August 29 2016

The CFPB has entered into a Consent Order with Wells Fargo Bank, N.A. Asserting that it engaged in unfair and deceptive practices related to its

OIG Issues Favorable Advisory Opinion on Prescription Drug Discount Program
  • Hall Render Killian Heath & Lyman PC
  • USA
  • August 11 2016

The Department of Health and Human Services Office of Inspector General (“OIG”) recently issued a favorable Advisory Opinion, No. 16-07, of an

OIG Permits Copayment Coupon Arrangement for Statutorily Non-Covered Drug in Advisory Opinion 16-07
  • Ober Kaler
  • USA
  • July 16 2016

On June 20, 2016, the U.S. Department of Health and Human Services Office of Inspector General (OIG) issued a favorable Advisory Opinion 16-07

Latest TCCWNA Class Action Could Transform SellerConsumer Relationship
  • Hunton & Williams LLP
  • USA
  • July 14 2016

The tidal wave of New Jersey Truth-in-Consumer Contract, Warranty and Notice Act ("TCCWNA") claims just swept up a novel argument: a class complaint